Xiaoding Xu

Xiaoding Xu

Harvard University

H-index: 48

North America-United States

About Xiaoding Xu

Xiaoding Xu, With an exceptional h-index of 48 and a recent h-index of 37 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Nanomedicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges

Remodeling of Mitochondrial Metabolism by a Mitochondria‐Targeted RNAi Nanoplatform for Effective Cancer Therapy

Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance

Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy

Nanoparticles (NPs)-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis

Supramolecular peptide hydrogel doped with nanoparticles for local siRNA delivery and diabetic wound healing

Role of long non-coding RNAs (lncRNAs) in cancer: from subcellular localization to nanoparticles (NPs)-mediated targeted regulation

Bioactive lipid-nanoparticles with inherent self-therapeutic and anti-angiogenic properties for cancer therapy

Xiaoding Xu Information

University

Position

Harvard Medical School

Citations(all)

7457

Citations(since 2020)

4606

Cited By

4651

hIndex(all)

48

hIndex(since 2020)

37

i10Index(all)

102

i10Index(since 2020)

84

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Xiaoding Xu Skills & Research Interests

Nanomedicine

Top articles of Xiaoding Xu

Title

Journal

Author(s)

Publication Date

Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges

Lei Xu

Yuan Cao

Ya Xu

Rong Li

Xiaoding Xu

2024/3

Remodeling of Mitochondrial Metabolism by a Mitochondria‐Targeted RNAi Nanoplatform for Effective Cancer Therapy

Small

Rui Xu

Linzhuo Huang

Jiayu Liu

Yuxuan Zhang

Ya Xu

...

2024/3

Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance

Jing Cai

Xiaoding Xu

Phei Er Saw

2024/1

Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy

Acta Pharmaceutica Sinica B

Zhihui Dong

Zhuoshan Huang

Senlin Li

Ying Wang

Yandan Yao

...

2023/3/1

Nanoparticles (NPs)-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis

Acta Pharmaceutica Sinica B

Ke Yang

Lei Xu

Ying Xu

Qian Shen

Tao Qin

...

2023/8/1

Supramolecular peptide hydrogel doped with nanoparticles for local siRNA delivery and diabetic wound healing

Chemical Engineering Journal

Liangyan Wu

Yanbo Chen

Gang Zeng

Na Mao

Na Li

...

2023/2/1

Role of long non-coding RNAs (lncRNAs) in cancer: from subcellular localization to nanoparticles (NPs)-mediated targeted regulation

Chunfang Wei

Ya Xu

Qian Shen

Rong Li

Xiaoyun Xiao

...

2023/7/16

Bioactive lipid-nanoparticles with inherent self-therapeutic and anti-angiogenic properties for cancer therapy

Acta Biomaterialia

Shuwen Cao

Wenyue Zhang

Hehai Pan

Ziqi Huang

Mingyan Guo

...

2023/2/1

Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib

Advanced Science

Senlin Li

Lei Xu

Guo Wu

Ziqi Huang

Linzhuo Huang

...

2023/7

Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy

Acta Pharmaceutica Sinica B

Xiaodi Liu

Qi Zhang

Yixia Liang

Shiyu Xiong

Yan Cai

...

2023/12/1

Corrigendum to" Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy"[Biomater. 234 (2020) 119760]

Biomaterials

Senlin Li

Phei Er Saw

Chunhao Lin

Yan Nie

Wei Tao

...

2023/2

Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy

Acta Biomaterialia

Linzhuo Huang

Rui Xu

Weirong Li

Li Lv

Chunhao Lin

...

2023/5/1

LARAI portal provides a safe method for lateral meniscus repair: three-dimensional computed tomography and cadaveric assessment

Journal of Orthopaedics and Traumatology

Yi Long

Zhengzheng Zhang

Min Zhou

Jingyi Hou

Yunfeng Zhou

...

2023/9/29

HPV enhances HNSCC chemosensitization by inhibiting SERPINB3 expression to disrupt the fanconi anemia pathway

Advanced Science

Zixian Huang

Yongju Chen

Rui Chen

Bin Zhou

Yongqiang Wang

...

2023/1

Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling

Journal of Experimental & Clinical Cancer Research

Zixian Huang

Xi Rui

Chen Yi

Yongju Chen

Rui Chen

...

2023/3/11

The critical shoulder angle can be accurately and reliably determined from three‐dimensional computed tomography images

Orthopaedic Surgery

Yi Long

Huijun Hu

Chuanhai Zhou

Jingyi Hou

Zhiling Wang

...

2023/8

Stimuli-responsive nanoparticles for biomedical applications

2022/7/21

Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis

Qian Shen

Rong Liu

Shiyu Tan

Xiaoding Xu

Junyue Fang

...

2022/12/22

Nanoparticles‐Mediated CRISPR/Cas Gene Editing Delivery System

Phei Er Saw

Guo‐hui Cui

Xiaoding Xu

2022/5/4

Small molecular inhibitors reverse cancer metastasis by blockading oncogenic PITPNM3

Advanced Science

Zihao Liu

Yu Shi

Li Lv

Jianing Chen

WenG Jiang

...

2022/12

See List of Professors in Xiaoding Xu University(Harvard University)